Saturday, November 15, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

AdyenV Stock: Plunges 20% on Growth Forecast Cut

Felix Baarz by Felix Baarz
August 14, 2025
in Stocks
0
AdyenV Stock
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Dutch fintech giant AdyenV faced a brutal selloff, with shares crashing nearly 20% to €1,212.6 after slashing its 2024 growth outlook due to geopolitical tensions. The company cited weakened transaction volumes from Asia-Pacific online retailers, spooked by U.S. tariff threats, as the primary driver. First-half revenue grew 20% to €1.1 billion but missed expectations, while payment volume stagnated at 5% growth—far below historical trends. Analysts expressed sharp divisions, with some viewing the dip as a buying opportunity and others warning of prolonged pressure.

Profitability Holds Amid Turmoil

Despite the growth setback, AdyenV maintained strong operational metrics: net profit rose 17% to €481 million, with EBITDA margins expanding to 50%. Management reaffirmed long-term targets of 20–30% revenue growth by 2026 but acknowledged near-term headwinds. Technical charts show the stock testing April lows, with bears dominating sentiment. Investors now await clearer signals of a rebound, particularly in Asian markets, to justify a recovery.

Ad

AdyenV Stock: Buy or Sell?! New AdyenV Analysis from November 15 delivers the answer:

The latest AdyenV figures speak for themselves: Urgent action needed for AdyenV investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 15.

AdyenV: Buy or sell? Read more here...

Tags: AdyenV
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Royal Gold Stock
Stocks

Royal Gold Shares Surge to Record High on Acquisition Momentum

September 29, 2025
Unitedhealth Stock
Stocks

UnitedHealth Shares Present Conflicting Outlook for Investors

September 29, 2025
ASML Stock
Stocks

ASML Forges Strategic AI Alliance to Bolster Semiconductor Dominance

September 29, 2025
Next Post
Jost Werke Stock

Jost Werke Stock: Defying Market Slump with Strategic Growth

PNE Stock

PNE Stock: Wind Woes Widen Losses Despite Revenue Growth

MUT Stock

MUT Stock: Sharp Downgrade Amid Q2 Nightmare

Recommended

IonQ Stock

IonQ’s Patent Portfolio Surge Signals Quantum Computing Ambition

3 months ago
Biotechnology Market Capitalization

Analyst Expresses Optimistic View on Palo Alto Networks Raises Price Target

2 years ago
Electric Utilities Stock Bull Market

Xcel Energys Q4 Earnings Report and Future Guidance

2 years ago
Salesforce Stock

Salesforce Shares Slide Following CEO’s Stock Disposal

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Cloudflare Positions for AI Leadership with Strategic Data Initiative

Marvell Technology Shares Face Mounting Pressure

Vertex’s Billion-Dollar Bet on Alpine Immune Sciences: A Strategic Analysis

WiMi Unveils Quantum AI Breakthrough for Holographic Imaging

iSun’s Final Chapter: Liquidation Wipes Out Shareholder Value

Rafael Shares Plummet Amid Technical Warnings and Weak Earnings

Trending

Phathom Pharmaceuticals Stock
Earnings

Phathom Pharmaceuticals Stock Surges on Strong Quarterly Performance

by Dieter Jaworski
November 15, 2025
0

Phathom Pharmaceuticals is demonstrating remarkable momentum in the market, fueled by unexpectedly robust quarterly earnings and significant...

Verve Therapeutics Stock

Verve Therapeutics Acquisition Marks New Chapter in Gene Editing

November 15, 2025
Intel Stock

Chip Sector Showdown: AMD’s AI Surge Versus Intel’s Turnaround Bid

November 15, 2025
Cloudflare Stock

Cloudflare Positions for AI Leadership with Strategic Data Initiative

November 15, 2025
Marvell Technology Stock

Marvell Technology Shares Face Mounting Pressure

November 15, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Phathom Pharmaceuticals Stock Surges on Strong Quarterly Performance
  • Verve Therapeutics Acquisition Marks New Chapter in Gene Editing
  • Chip Sector Showdown: AMD’s AI Surge Versus Intel’s Turnaround Bid

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com